Evidence map›Paper›PMID 40611090›Full record

ArticleBMC health services research2025

Looking ahead! the feasibility of implementing remote patient monitoring for high-risk oncology patients.

AnnMarie Mazzella-Ebstein, Hayley Dunnack-Yackel, Robert Michael Daly, Andrew L Salner, Mary Kate Eanniello, Sara Fontaine, Jennie Huang, Camila Bernal, Clare Wilhelm, Jill Ackerman and 4 more

Abstract read
In one paragraph

Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

AnnMarie Mazzella-EbsteinMemorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA. mazzella@mskcc.org.
Hayley Dunnack-YackelHartford Health Care Cancer Institute, 85 Retreat Avenue #2, Hartford, CT, 06106, USA.
Robert Michael DalyMemorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA.
Andrew L SalnerHartford Health Care Cancer Institute, 85 Retreat Avenue #2, Hartford, CT, 06106, USA.
Mary Kate EannielloHartford Health Care Cancer Institute, 85 Retreat Avenue #2, Hartford, CT, 06106, USA.
Sara FontaineHartford Health Care Cancer Institute, 85 Retreat Avenue #2, Hartford, CT, 06106, USA.
Jennie HuangMemorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA.
Camila BernalMemorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA.
Clare WilhelmMemorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA.
Jill AckermanMemorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA.
Katherine S PanageasMemorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA.
Gilad KupermanMemorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA.
Jun MaoMemorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA.
Margaret Barton-BurkeMemorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY, 10065, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
MSK Cancer Center Support Grant P30 CA 008748NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundThe goal of posthospital care delivery is to improve patient access to providers and prevent unnecessary readmissions. This study assessed the feasibility, barriers, and facilitating factors of implementing remote patient monitoring (RPM) for oncology patients at the Hartford HealthCare Cancer Institute (HHC), Hartford CT, and a state-wide healthcare system.

methodsA multi-model holistic approach to quantitative surveys, and qualitative interviews and focus groups were used to collect insights from hospital stakeholders about the culture, learning, leadership, and resources for implementing RPM. Stakeholders from HHC responded to the survey between September 1st through September 30th, 2022. The frequency and percentage distributions for survey item responses were calculated. Items with the highest percentage and frequency of neutral and disagreement responses informed the interview guide. A purposeful sample of hospital stakeholders and patients were recruited for interviews and focus groups, which were conducted from January 1st through January 30th, 2023. Current and future state organizational maps of clinical care models and processes were developed.

resultsSixty-three stakeholders were sent the Readiness for Implementation Survey and 53 responded through an email link to a web-based database (84% response rate). Responses supported RPM to improve patient care (67%). Interviews and focus groups elicited stakeholder perceptions of implementing change, the change climate, available resources, and barriers and facilitators of RPM. Stakeholders (n = 78), inclusive of the 63 survey recipients, plus 15 stakeholders from the Cancer Patient and Family Advisory Council (PFAC) and hospital staff, agreed to participate in interviews and focus groups. Fifty-two individuals (67% response rate) agreed to participate. Eight individual interviews and 6 focus groups were conducted. The emerged themes included integrating change into hospital systems, relevance to patient care teams, and patient- and family-centered care. Subthemes were subsequently explored.

conclusionStakeholders endorsed using RPM to improve communication among providers and patients’ access to care. Providers underscored key elements for program success that include a designated intervention team, strategies to assess symptom alerts, and an enterprise-wide availability of clinical data in future RPM development. Patient stakeholders emphasized integrating a patient-centered approach to RPM development.

Indexed as

NeoplasmsRemote Patient MonitoringFeasibility StudiesFemaleFocus GroupsHumansInterviews as TopicQualitative ResearchSurveys and QuestionnairesCancerFeasibilityOncologyRemote patient monitoringStakeholdersUsability

Identifiers

PMID40611090
PMCPMC12224688

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.